• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.在采用移植后环磷酰胺的大规模单倍体造血干细胞移植中,严重感染和感染相关死亡率。
Bone Marrow Transplant. 2021 Oct;56(10):2432-2444. doi: 10.1038/s41409-021-01328-4. Epub 2021 May 31.
2
Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.单倍体与同胞相合供者在成人急性淋巴细胞白血病造血干细胞移植中的结局:欧洲血液和骨髓移植学会急性白血病工作组的一项研究。
J Hematol Oncol. 2021 Apr 1;14(1):53. doi: 10.1186/s13045-021-01065-7.
3
Patterns of infection and infectious-related mortality in patients receiving post-transplant high dose cyclophosphamide as graft-versus-host-disease prophylaxis: impact of HLA donor matching.接受移植后高剂量环磷酰胺预防移植物抗宿主病的患者的感染模式和感染相关死亡率:HLA 供体匹配的影响。
Bone Marrow Transplant. 2021 Apr;56(4):818-827. doi: 10.1038/s41409-020-01092-x. Epub 2020 Oct 26.
4
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.降低强度预处理方案联合抗胸腺细胞球蛋白和移植后环磷酰胺预防移植物抗宿主病在血缘单倍体造血干细胞移植治疗血液系统恶性肿瘤中的应用。
Biol Blood Marrow Transplant. 2018 Nov;24(11):2259-2264. doi: 10.1016/j.bbmt.2018.07.008. Epub 2018 Aug 7.
5
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching.异基因移植后使用环磷酰胺后的感染:供体 HLA 匹配的影响。
Biol Blood Marrow Transplant. 2020 Jun;26(6):1179-1188. doi: 10.1016/j.bbmt.2020.01.013. Epub 2020 Jan 28.
6
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant Cyclophosphamide.接受移植后环磷酰胺的 HLA 匹配和单倍体相合供者造血干细胞移植中 BK 出血性膀胱炎的发病率、危险因素及结局
Transplant Cell Ther. 2025 Mar;31(3):182.e1-182.e11. doi: 10.1016/j.jtct.2024.12.006. Epub 2024 Dec 17.
7
Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study.低剂量抗胸腺细胞球蛋白联合低剂量移植后环磷酰胺方案预防单倍体外周血造血干细胞移植后移植物抗宿主病:一项大样本、长期随访的回顾性研究。
Front Immunol. 2023 Oct 26;14:1252879. doi: 10.3389/fimmu.2023.1252879. eCollection 2023.
8
Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT.移植后环磷酰胺预防单倍体 HSCT 后慢性活动性 EBV 感染患儿移植物抗宿主病
Orphanet J Rare Dis. 2022 Dec 2;17(1):422. doi: 10.1186/s13023-022-02585-2.
9
Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies.抗胸腺细胞球蛋白联合移植后环磷酰胺预防方案在亲缘单倍体外周血造血干细胞移植治疗血液系统恶性肿瘤中的应用。
Int J Hematol. 2022 Apr;115(4):525-533. doi: 10.1007/s12185-021-03280-x. Epub 2022 Feb 28.
10
Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease.在慢性肉芽肿病中,采用移植后环磷酰胺的单倍体相合造血细胞移植未能预防严重移植物抗宿主病。
J Clin Immunol. 2020 May;40(4):619-624. doi: 10.1007/s10875-020-00772-z. Epub 2020 Apr 20.

引用本文的文献

1
Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.不匹配无关供者外周血干细胞移植后基于移植后环磷酰胺的移植物抗宿主病预防
J Clin Oncol. 2025 Jun 16:JCO2500856. doi: 10.1200/JCO-25-00856.
2
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry.在一个拥有大量无关供者登记库的发展中国家,单倍型相合、亲缘匹配和无关匹配造血细胞移植用于急性白血病的情况(该研究处于单倍型相合移植实施的早期阶段)
Front Oncol. 2025 Apr 15;15:1584631. doi: 10.3389/fonc.2025.1584631. eCollection 2025.
3
Blood Virome After Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后的血液病毒组
Open Forum Infect Dis. 2025 Apr 10;12(4):ofaf213. doi: 10.1093/ofid/ofaf213. eCollection 2025 Apr.
4
Post-Transplant Cyclophosphamide-Based Prophylaxis and Its Impact on Infectious Complications and Immune Reconstitution According to Donor Type.基于移植后环磷酰胺的预防措施及其对根据供体类型的感染并发症和免疫重建的影响。
Cancers (Basel). 2025 Mar 26;17(7):1109. doi: 10.3390/cancers17071109.
5
Efficacy and safety of early antibiotic de-escalation in febrile neutropenia for patients with hematologic malignancy: a systematic review and meta-analysis.血液系统恶性肿瘤患者发热性中性粒细胞减少症早期抗生素降阶梯治疗的疗效与安全性:一项系统评价和荟萃分析
Antimicrob Agents Chemother. 2025 Apr 2;69(4):e0159724. doi: 10.1128/aac.01597-24. Epub 2025 Mar 13.
6
Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post-Transplant Cyclophosphamide.具有双细胞来源及移植后环磷酰胺的单倍体相合干细胞移植
Cancer Med. 2025 Feb;14(3):e70541. doi: 10.1002/cam4.70541.
7
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.15年来,通过同情用药获得病毒特异性T细胞进行过继性免疫治疗。
Nat Commun. 2024 Dec 3;15(1):10339. doi: 10.1038/s41467-024-54595-2.
8
Outcomes in hematopoetic cell transplantation in the setting of mold infections in patients with chronic granulomatous disease.慢性肉芽肿病患者发生霉菌感染时造血细胞移植的结局
Bone Marrow Transplant. 2025 Feb;60(2):191-200. doi: 10.1038/s41409-024-02389-x. Epub 2024 Nov 4.
9
A comparison of haploidentical versus HLA-identical sibling outpatient hematopoietic cell transplantation using reduced intensity conditioning in patients with acute leukemia.比较亲缘单倍体与 HLA 同型相匹配同胞供者在急性白血病患者中采用减低强度预处理方案的门诊造血细胞移植。
Front Immunol. 2024 Oct 4;15:1400610. doi: 10.3389/fimmu.2024.1400610. eCollection 2024.
10
Pre-engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis.异基因造血细胞移植后未进行初始氟喹诺酮类抗菌药物预防的植入前菌血症
Transpl Infect Dis. 2024 Dec;26(6):e14375. doi: 10.1111/tid.14375. Epub 2024 Sep 23.

本文引用的文献

1
Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.未处理的单倍体相合异基因造血干细胞移植联合移植后环磷酰胺后巨细胞病毒特异性T细胞免疫的重建
Bone Marrow Transplant. 2020 Jul;55(7):1347-1356. doi: 10.1038/s41409-020-0865-x. Epub 2020 Mar 23.
2
Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.成人异基因造血干细胞移植后,急性胃肠道移植物抗宿主病的严重程度与血流感染的发生率相关。
Transpl Infect Dis. 2020 Feb;22(1):e13217. doi: 10.1111/tid.13217. Epub 2019 Dec 9.
3
Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.在采用移植后环磷酰胺的非处理单倍体相合异基因造血干细胞移植中巨细胞病毒血症的发生率、特征及结局
Transpl Infect Dis. 2020 Feb;22(1):e13206. doi: 10.1111/tid.13206. Epub 2019 Nov 15.
4
Immune reconstitution after T-cell replete HLA-haploidentical transplantation.T 细胞完全 HLA 单倍体移植后的免疫重建。
Semin Hematol. 2019 Jul;56(3):221-226. doi: 10.1053/j.seminhematol.2019.03.005. Epub 2019 Mar 26.
5
Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling Transplantation.单倍体造血干细胞移植后植入前血流感染的发生率、危险因素、微生物学和结局及与 HLA 同胞供者移植的比较。
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S162-S173. doi: 10.1093/cid/ciy658.
6
Haploidentical unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: a report on 1578 patients from the Acute Leukemia Working Party of the EBMT.亲缘半相合非亲缘异基因造血干细胞移植治疗复发/难治性急性髓系白血病:来自 EBMT 急性白血病工作组的 1578 例患者报告。
Haematologica. 2019 Mar;104(3):524-532. doi: 10.3324/haematol.2017.187450. Epub 2018 Oct 25.
7
Busulfan-based myeloablative conditioning regimens for haploidentical transplantation in high-risk acute leukemias and myelodysplastic syndromes.基于白消安的清髓性预处理方案在高危急性白血病和骨髓增生异常综合征的单倍体相合移植中的应用。
Eur J Haematol. 2018 Sep;101(3):332-339. doi: 10.1111/ejh.13103. Epub 2018 Aug 3.
8
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.造血干细胞移植受者菌血症革兰氏阴性杆菌的耐药性:欧洲骨髓移植协作组传染病工作组的国际前瞻性研究。
Clin Infect Dis. 2017 Nov 13;65(11):1819-1828. doi: 10.1093/cid/cix646.
9
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey.异基因和自体造血干细胞移植后植入前革兰氏阴性菌血症的发生率、危险因素和结局:意大利前瞻性多中心调查。
Clin Infect Dis. 2017 Nov 13;65(11):1884-1896. doi: 10.1093/cid/cix690.
10
Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.异基因造血干细胞移植治疗急性髓系白血病患者中,多重耐药菌定植对预后的临床影响。
Cancer. 2018 Jan 15;124(2):286-296. doi: 10.1002/cncr.31045. Epub 2017 Sep 28.

在采用移植后环磷酰胺的大规模单倍体造血干细胞移植中,严重感染和感染相关死亡率。

Severe infections and infection-related mortality in a large series of haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide.

机构信息

Hematology Department, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau and Jose Carreras Leukemia Research Institutes, Universitat Autonoma of Barcelona, Barcelona, Spain.

Hematology Department, Hospital Regional Universitario, Malaga, Spain.

出版信息

Bone Marrow Transplant. 2021 Oct;56(10):2432-2444. doi: 10.1038/s41409-021-01328-4. Epub 2021 May 31.

DOI:10.1038/s41409-021-01328-4
PMID:34059802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8165955/
Abstract

Severe infections and their attributable mortality are major complications in recipients of allogeneic hematopoietic stem cell transplantation (alloSCT). We herein report 236 adult patients who received haploSCT with PTCy. The median follow-up for survivors was 37 months. The overall incidence of bloodstream infections by gram-positive and gram-negative bacteria at 37 months was 51% and 46%, respectively. The incidence of cytomegalovirus infection was 69%, while Epstein Barr virus infections occurred in 10% of patients and hemorrhagic cystitis in 35% of cases. Invasive fungal infections occurred in 11% at 17 months. The 3-year incidence of infection-related mortality was 19%. The median interval from transplant to IRM was 3 months (range 1-30), 53% of IRM occurred >100 days post-haploSCT. Risk factors for IRM included age >50 years, lymphoid malignancy, and developing grade III-IV acute GvHD. Bacterial infections were the most common causes of IRM (51%), mainly due to gram-negative bacilli BSI. In conclusion, severe infections are the most common causes of NRM after haploSCT with PTCy, with a reemergence of gram-negative bacilli as the most lethal pathogens. More studies focusing on the severe infections after haploSCT with PTCy and differences with other types of alloSCT in adults are clearly warranted.

摘要

严重感染及其相关死亡率是异基因造血干细胞移植(alloSCT)受者的主要并发症。我们在此报告了 236 例接受 PTCy 单倍体造血干细胞移植的成年患者。幸存者的中位随访时间为 37 个月。37 个月时,血流感染革兰阳性菌和革兰阴性菌的总发生率分别为 51%和 46%。巨细胞病毒感染的发生率为 69%,而 EBV 感染发生率为 10%,出血性膀胱炎发生率为 35%。侵袭性真菌感染在 17 个月时的发生率为 11%。3 年感染相关死亡率为 19%。从移植到 IRM 的中位时间为 3 个月(范围 1-30),53%的 IRM 发生在单倍体造血干细胞移植后>100 天。IRM 的危险因素包括年龄>50 岁、淋巴恶性肿瘤和发生 3-4 级急性移植物抗宿主病。细菌感染是 IRM 的最常见原因(51%),主要是由于革兰氏阴性菌菌血症。总之,在接受 PTCy 单倍体造血干细胞移植后,严重感染是导致 NRM 的最常见原因,革兰氏阴性菌再次成为最致命的病原体。显然,需要更多的研究来关注 PTCy 单倍体造血干细胞移植后严重感染以及与成人其他类型 alloSCT 的差异。